mipomersen 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
antisense oligonucleotides 4747 629167-92-6

Description:

MoleculeDescription

Synonyms:

  • mipomersen
  • mipomersen sodium
  • kynamro
  • ISIS 301012
  • ISIS-301012
an antisense oligonucleotide that binds apolipoprotein B mRNA and inhibits expression of apoB
  • Molecular weight: 7594.76
  • Formula: C230H305N67Na19O122P19S19
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 2603.20
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

Approvals:

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Drug Use | Suggest Off label Use Form| |View source of the data|




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

Pharmaceutical products:

mipomersen